Stock 6652 EUSOL BIOTECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Eusol Biotech Co.,Ltd.

Equities

6652

TW0006652001

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 23/05/2024 am IST 		5-day change 1st Jan Change
8.25 TWD +3.00% Intraday chart for Eusol Biotech Co.,Ltd. +1.73% -12.79%
17/04 Eusol Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,378 2,444 3,156 2,028 1,110 1,296
Enterprise Value (EV) 1 3,129 2,302 3,091 1,754 720.7 920.7
P/E ratio -17.2 x -22.8 x -27.7 x -16.1 x -60.6 x -25.1 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -15.6 x -25.6 x -34.5 x -17.7 x -12.7 x -23.1 x
EV / FCF -15.1 x -43.4 x -62.8 x -40.3 x -27.8 x -30.6 x
FCF Yield -6.62% -2.3% -1.59% -2.48% -3.6% -3.27%
Price to Book 7.01 x 6.68 x 12.1 x 4.67 x 2.63 x 3.23 x
Nbr of stocks (in thousands) 1,25,000 1,25,000 1,25,000 1,37,000 1,37,000 1,37,000
Reference price 2 27.02 19.55 25.25 14.80 8.100 9.460
Announcement Date 22/04/19 28/04/20 12/04/21 30/03/22 24/03/23 17/04/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -200.3 -89.94 -89.6 -99.3 -56.96 -39.86
EBIT 1 -223.6 -114 -114.2 -122.8 -76.76 -41.48
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -194.3 -107.3 -113.5 -123.6 -12.29 -49.12
Net income 1 -194.3 -107.3 -113.8 -123.3 -18.31 -51.61
Net margin - - - - - -
EPS 2 -1.569 -0.8580 -0.9102 -0.9199 -0.1336 -0.3767
Free Cash Flow 1 -207.2 -53.01 -49.22 -43.5 -25.96 -30.1
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 22/04/19 28/04/20 12/04/21 30/03/22 24/03/23 17/04/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 248 142 65 274 389 375
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -207 -53 -49.2 -43.5 -26 -30.1
ROE (net income / shareholders' equity) -38.7% -25.3% -36.3% -35.5% -4.28% -12.5%
ROA (Net income/ Total Assets) -24.9% -16% -21.2% -20.9% -10.7% -6.09%
Assets 1 781.5 669.4 536.6 591.4 170.9 847.1
Book Value Per Share 2 3.860 2.930 2.090 3.170 3.080 2.930
Cash Flow per Share 2 1.990 1.230 0.5800 1.810 1.060 1.560
Capex 1 80.2 11.8 1.63 0.56 - 0.07
Capex / Sales - - - - - -
Announcement Date 22/04/19 28/04/20 12/04/21 30/03/22 24/03/23 17/04/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
EUSOL BIOTECH CO.,LTD. Stock Eusol Biotech Co.,Ltd.
-12.79% 33.97M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.69% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.24% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.12% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.35% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6652 Stock
  4. Financials Eusol Biotech Co.,Ltd.